The Company is an investment trust and its shares are listed on the Official List and traded on the main market of the London Stock Exchange.

The Company

The Company is a member of the Association of Investment Companies (“AIC”). Total assets less current liabilities as at 31 March 2019 were £408.9 million and the market capitalisation was £381.4 million.

Management

The Company employs OrbiMed Capital LLC (“OrbiMed”) as Portfolio Manager. Frostrow Capital LLP (“Frostrow”) provides AIFM, company secretarial, administrative and marketing services.

Portfolio Manager

OrbiMed Capital LLC
601 Lexington Avenue, 54th Floor
New York NY10022 USA

Telephone: +1 212 739 6400
Website: www.orbimed.com

Registered under the U.S. Securities and Exchange Commission.

AIFM, Company Secretary and Administrator

Frostrow Capital LLP
25 Southampton Buildings
London WC2A 1AL

Telephone: 0203 008 4910
E-Mail: info@frostrow.com
Website: www.frostrow.com

Authorised and regulated by the Financial Conduct Authority.

Performance

Performance is measured against the NASDAQ Biotechnology Index (sterling adjusted).

Independent Auditor

Ernst & Young LLP
1 More London Place
London SE1 2AF

Capital Structure

The Company’s capital structure is composed solely of Ordinary Shares.

Depositary

JP Morgan Europe Limited
25 Bank Street
London E14 5JP
United Kingdom

Dividend

No dividend is recommended in respect of the year ended 31 March 2017 (2016: nil).

Custodian and Prime Broker

JP Morgan Securities LLC
Suite 1, Metro Tech Roadway
Brooklyn NY 11201
United States of America

Continuation Vote

The next continuation vote of the Company shall be held at the Annual General Meeting in 2020, and further opportunities to vote on the continuation of the Company shall be given to shareholders every five years thereafter.

Registrars

Link Asset Services
The Registry
34 Beckenham Road
Beckenham
Kent BR3 4TU

Telephone (in UK): 0871 664 0300
Telephone (from overseas):
+371 664 0 300

E-Mail: enquiries@linkgroup.co.uk

Website: www.linkassetservices.com

ISA Status

The Company’s shares are eligible for Individual Savings Accounts (‘ISAs’) and for Junior ISAs.

Brokers

Winterflood Securities Limited
The Atrium Building
Cannon Bridge
25 Dow Gate Hill
London EC4R 2GA

Registered Office

One Wood Street
London EC2V 7WS

Solicitors

Charles Russell Speechlys
5 Fleet Place
EC4M 7RS

Identification Codes

Shares: SEDOL: 0038551

ISIN: GB0000385517

GIIN: U1MQ70.99999.SL.826

BLOOMBERG: BIOG LN

EPIC: BIOG

Company Registration Number

3376377 (Registered in England and Wales)

The Company is an investment company as defined under Section 833 of the Companies Act 2006. The Company was incorporated in England on 20 May 1997 as Reabourne Merlin Life Sciences Investment Trust PLC.

Legal Entity Identifier

549300Z41EP32MI2DN29